<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a group of stem cell disorders characterized by a reduction in one or more elements of the peripheral blood </plain></SENT>
<SENT sid="1" pm="."><plain>Oral manifestations of the disease and oral complications of medical management may result in significant symptoms and have an impact on the systemic condition of the patient </plain></SENT>
<SENT sid="2" pm="."><plain>The removal of the infectious focus, such active teeth <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or severe <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e>, remains controversial in these patients, due to the increased risk of <z:mp ids='MP_0001914'>bleeding</z:mp> and <z:e sem="disease" ids="C0243026" disease_type="Disease or Syndrome" abbrv="">systemic infection</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: This paper reports a case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with spontaneous gingival <z:mp ids='MP_0001914'>hemorrhage</z:mp> and generalized <z:hpo ids='HP_0000212'>gingival hyperplasia</z:hpo> associated with <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This patient underwent several platelet transfusions due to these oral complications </plain></SENT>
<SENT sid="5" pm="."><plain>The patient received periodontal therapy, resulting in an improvement of the oral clinical situation and a decrease of <z:hpo ids='HP_0000212'>gingival hyperplasia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The patient did not present any episode of gingival <z:mp ids='MP_0001914'>hemorrhage</z:mp> after the periodontal treatment </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The results of this study suggest that periodontal therapy should be performed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients presenting <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0000212'>gingival hyperplasia</z:hpo>, and <z:hpo ids='HP_0000225'>gingival bleeding</z:hpo>, with the intent of preventing further hemorrhagic episodes and possible <z:e sem="disease" ids="C0243026" disease_type="Disease or Syndrome" abbrv="">systemic infection</z:e> </plain></SENT>
</text></document>